Literature DB >> 28179316

Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer.

Hanne R Hagland1,2,3, Dordi Lea1,4, Martin M Watson1,3, Kjetil Søreide5,3,6.   

Abstract

AIM: To test the feasibility of conducting parallel analyses of circulating T-cells in blood and intratumoural T-cells in colorectal cancer. A pre-operative 'liquid biopsy' to determine immune status would facilitate clinical decision-making.
MATERIALS AND METHODS: A total of 18 patients with stage I-III colorectal cancer (CRC) were included. Blood was analyzed for T-cell type (CD3+, CD4+ and CD8+) and count using flow cytometry. Intratumoural T-cells were stained using immunohistochemistry and quantified by digital pathology. Tumour location was defined as invasive front (IF) or tumour center (TC).
RESULTS: The number of CD3+ and CD4+ T-cells in pre-surgical blood samples correlated with the number of CD3+ T-cells found in the IF (Spearman ϱ=0.558, p<0.05 and 0.598, p<0.01 respectively) and CD3+ in the TC (ϱ=0.496, p<0.05, and ϱ=0.637, p<0.01, respectively). A strong correlation was found between CD4+ cells in blood and CD8+ T-cells found in the TC and IF (ϱ=0.602 and ϱ=0.591, p<0.01).
CONCLUSION: There is a correlation between blood CD3+ and CD4+ T-cells and the T-cells found at the TC and IF. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CD3+; CD4+; CD8+; Colorectal cancer; T-cells; cancer immune response; liquid biopsies; tumour center; tumour invasive front

Mesh:

Substances:

Year:  2017        PMID: 28179316     DOI: 10.21873/anticanres.11363

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Circulating Lymphocytes Reflect the Local Immune Response in Patients with Colorectal Carcinoma.

Authors:  Johanna Waidhauser; Pia Nerlinger; Florian Sommer; Sebastian Wolf; Stefan Eser; Phillip Löhr; Andreas Rank; Bruno Märkl
Journal:  Diagnostics (Basel)       Date:  2022-06-07

2.  A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.

Authors:  Dordi Lea; Martin Watson; Ivar Skaland; Hanne R Hagland; Melinda Lillesand; Einar Gudlaugsson; Kjetil Søreide
Journal:  Cancer Immunol Immunother       Date:  2021-01-13       Impact factor: 6.968

3.  Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma.

Authors:  Johanna Waidhauser; Pia Nerlinger; Tim Tobias Arndt; Stefan Schiele; Florian Sommer; Sebastian Wolf; Phillip Löhr; Stefan Eser; Gernot Müller; Rainer Claus; Bruno Märkl; Andreas Rank
Journal:  Cancer Immunol Immunother       Date:  2021-12-20       Impact factor: 6.630

Review 4.  Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.

Authors:  Bilikis Aderonke Abolarinwa; Ridwan Babatunde Ibrahim; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

5.  Antitumor and antioxidant effects of Clinacanthus nutans Lindau in 4 T1 tumor-bearing mice.

Authors:  Nik Mohd Afizan Nik Abd Rahman; M Y Nurliyana; M N F Natasha Nur Afiqah; Mohd Azuraidi Osman; Muhajir Hamid; Mohd Azmi Mohd Lila
Journal:  BMC Complement Altern Med       Date:  2019-11-29       Impact factor: 3.659

Review 6.  A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy.

Authors:  Mercedes Herrera; Cristina Galindo-Pumariño; Vanesa García-Barberán; Cristina Peña
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

7.  Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients.

Authors:  Cieszymierz Gawiński; Wojciech Michalski; Andrzej Mróz; Lucjan Wyrwicz
Journal:  Biology (Basel)       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.